NORGES BANK - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$24,587,473
-29.2%
644,157
-6.9%
0.01%
-33.3%
Q3 2022$34,742,115
+27.4%
692,074
+1.6%
0.01%
+28.6%
Q2 2022$27,277,976
+29.9%
680,928
+21.0%
0.01%
+40.0%
Q1 2022$20,998,665
+27.1%
562,816
+35.7%
0.01%
+66.7%
Q4 2021$16,515,000
-19.2%
414,626
-24.5%
0.00%
-40.0%
Q3 2021$20,433,000
-6.9%
549,140
+5.7%
0.01%0.0%
Q2 2021$21,956,000
+4.0%
519,412
+16.5%
0.01%0.0%
Q1 2021$21,106,000
-37.6%
445,746
-19.6%
0.01%
-37.5%
Q4 2020$33,828,000
+42.7%
554,290
+9.3%
0.01%
+33.3%
Q3 2020$23,708,000
-18.6%
507,129
-11.6%
0.01%
-25.0%
Q2 2020$29,119,000
-2.9%
573,883
-14.7%
0.01%
-27.3%
Q1 2020$30,001,000
-5.2%
672,512
+2.0%
0.01%
+22.2%
Q4 2019$31,661,000
+47.6%
659,192
+3.9%
0.01%
+28.6%
Q3 2019$21,452,000
-22.4%
634,317
+3.2%
0.01%
-22.2%
Q2 2019$27,652,000
+577.7%
614,493
+467.0%
0.01%
+800.0%
Q1 2019$4,080,000
+143.0%
108,370
-13.6%
0.00%0.0%
Q3 2016$1,679,000
+579.8%
125,458
+255.6%
0.00%
Q2 2016$247,000
-65.2%
35,277
-68.0%
0.00%
Q1 2016$710,000
-80.1%
110,2910.0%0.00%
-100.0%
Q4 2015$3,574,000
-24.6%
110,291
-37.9%
0.00%0.0%
Q3 2015$4,741,000
-51.9%
177,558
-13.4%
0.00%
-60.0%
Q2 2015$9,865,000
+21.1%
204,952
+53.1%
0.01%
+25.0%
Q1 2015$8,147,000133,8840.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders